Faster access to new drugs doesn’t always mean better treatment

Faster access to new drugs doesn't always mean better treatment Weaker regulatory standards in the US can impact health everywhere. from shutterstock.com Narcyz Ghinea, University of Sydney and Wendy Lipworth, University of Sydney US President Donald Trump recently chose an adviser to a large pharmaceutical company to lead the country’s drug regulation agency. Scott Gottlieb